2022. Efficacy of hyaluronidase and dexamethasone intralesional injections in the management of oral submucous fibrosis. Journal of Pharmaceutical Negative Results. (Oct. 2022), 3495–3501. DOI:https://doi.org/10.47750/pnr.2022.13.S06.468.